ArticleCNS & neurological disorders drug targets2014

Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.

Qurrat ul Ain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.